Nuclear Medicine News and Research RSS Feed - Nuclear Medicine News and Research

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.
Coqui Pharma signs contract with INVAP to design Medical Isotope Production Facility in Alachua, Fla

Coqui Pharma signs contract with INVAP to design Medical Isotope Production Facility in Alachua, Fla

Coqui RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide. [More]
Breakthrough study shows novel molecular imaging drug to detect early prostate cancer

Breakthrough study shows novel molecular imaging drug to detect early prostate cancer

A novel study demonstrates the potential of a novel molecular imaging drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone. The research, published in the November issue of the Journal of Nuclear Medicine, compares the biodistribution and tumor uptake kinetics of two Tc-99m labeled ligands, MIP-1404 and MIP-1405, used with SPECT and planar imaging. [More]
UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center unveils new $800 million hospital

UT Southwestern Medical Center will unveil its new $800 million hospital at a dedication ceremony today. The 12-floor, 460-bed facility is being hailed as a patient-centered, state-of-the-art medical innovation for the people of Dallas, North Texas, and beyond. [More]
GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare’s advances in imaging quantitation may help clinicians diagnose disease earlier

GE Healthcare shares a suite of advances in imaging quantitation that may help clinicians diagnose disease earlier, deliver more personalised treatment and speed up care at the 27th annual meeting of the European Association of Nuclear Medicine (EANM), 18-22 October, in Gothenburg. [More]
New preclinical imaging product line launched by MILabs at the 2014 Annual European Association of Nuclear Medicine Meeting

New preclinical imaging product line launched by MILabs at the 2014 Annual European Association of Nuclear Medicine Meeting

MILabs BV has launched a complete new preclinical product line at the 2014 Annual European Association of Nuclear Medicine Meeting in Gothenburg, Sweden, October 18-22 (www.eanm.org). It consists of the new 4-series comprising U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT incorporating significant improvements over the former PLUS-series. The 4-series carries even further the tradition of MILabs to deliver the best SPECT and PET image resolution available in the market. [More]
Novel imaging technique could revolutionise diagnosis of neuroblastoma

Novel imaging technique could revolutionise diagnosis of neuroblastoma

CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed. [More]
Groups urge Medicare to cover LDCT screening for adults at high risk for lung cancer

Groups urge Medicare to cover LDCT screening for adults at high risk for lung cancer

More than 60 patient advocacy and medical organizations have joined a coalition headed by the Lung Cancer Alliance, the American College of Radiology and The Society of Thoracic Surgeons, in urging Medicare to cover low dose computed tomography (LDCT) screening for beneficiaries at high risk for lung cancer. [More]
Cancer community joins coalition seeking Medicare coverage for CT lung cancer screening

Cancer community joins coalition seeking Medicare coverage for CT lung cancer screening

More than 60 patient advocacy and medical organizations have joined a coalition headed by the Lung Cancer Alliance, the American College of Radiology and The Society of Thoracic Surgeons, in urging Medicare to cover low dose computed tomography (LDCT) screening for beneficiaries at high risk for lung cancer. [More]
Ultrasound procedures encourage many hospitals in Europe to adopt the technology

Ultrasound procedures encourage many hospitals in Europe to adopt the technology

Growing awareness of the harmful effects of radiation exposure is driving the uptake of ultrasound systems, which are radiation free, less expensive, and more versatile than bigger modalities such as magnetic resonance. [More]
Researchers develop new methods that improve quality of myocardial perfusion imaging

Researchers develop new methods that improve quality of myocardial perfusion imaging

New methods that enhance the quality of myocardial perfusion imaging were developed in a recent study completed at the University of Eastern Finland. [More]
Current x-ray- examinations capture only 20% of lung cancer cases

Current x-ray- examinations capture only 20% of lung cancer cases

Each year, nearly 3000 Norwegians develop lung cancer. Current x-ray- examinations capture only 20 percent of cases. With modern ultralow-dose CT, the radiologists hit the bull's eye 90 per cent of the time. [More]
Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Decline in daily functioning linked with Alzheimer's disease is related to alterations in brain activity

Decline in daily functioning associated with Alzheimer's disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer's Disease. [More]
PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

PET-CT using FDG-labeled leucocytes may help in detecting infection in patients with acute pancreatitis

A new study diagnosing infection in patients with pancreatic fluid collections may swiftly and accurately rule out active infection in the body. [More]

New less expensive method to enrich stable isotopes

Researchers at The University of Texas at Austin have devised a new method for enriching a group of the world's most expensive chemical commodities, stable isotopes, which are vital to medical imaging and nuclear power, as reported this week in the journal Nature Physics. For many isotopes, the new method is cheaper than existing methods. For others, it is more environmentally friendly. [More]

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators. [More]
Combination of MRI and PET imaging techniques can prevent second breast biopsy

Combination of MRI and PET imaging techniques can prevent second breast biopsy

Following a diagnosis of breast cancer, one of the hardest tasks is to distinguish the benign nodes in the breast from the malignant tumours, and this usually requires a tissue sample (biopsy) to be taken. [More]

Eden licenses Sandia’s technology to develop radioactive isotope for medical diagnostic tests

An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States. [More]
Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Groundbreaking molecular imaging agent developed to trace advanced prostate cancer

Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized-but some cases simply do not respond to this treatment. [More]
Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

With a new molecular imaging system powerful enough to peer down to 20-micrometer resolution, researchers can now use radioluminescence to examine the characteristics of single, unconnected cells. The result is a fascinating picture of diversity among cells previously assumed to behave the same, revealed researchers at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. [More]
REM sleep disorder: A sign of impending neurodegenerative disease

REM sleep disorder: A sign of impending neurodegenerative disease

How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting. [More]